Helene is the CEO of TriasBio, a venture-backed startup revolutionizing intelligent RNA design by leveraging LLMs trained on the language of biology. Driven by a mission to translate complex science into real-world applications, Helene leads TriasBio in developing "time-aware" RNA therapeutics that synchronize with the body’s biological clock.

A scientist turned entrepreneur, she holds a PhD from the University of Oxford and performed postdoctoral research at UC Berkeley. By bridging the gap between cutting-edge computational biology and clinical impact, she is dedicated to defining the next generation of precision medicine.